BIOTRICITY INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$416K
Free Cash Flow
$416K
Investing Cash Flow
—
Financing Cash Flow↑+69.7% +$296K
$721K
Capex
—
Dividends Paid
—
Stock-Based Comp↓-89.5% -$51K
$6K
Debt Issued
—
Debt Repaid
—
D&A↓-0.1% -$1
$1K
SBC Allocated Expense↓-89.5% -$51K
$6K